1. Home
  2. BGIN vs DCTH Comparison

BGIN vs DCTH Comparison

Compare BGIN & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BGIN

Bgin Blockchain Limited Class A Ordinary Shares

N/A

Current Price

$2.92

Market Cap

332.6M

Sector

N/A

ML Signal

N/A

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$9.25

Market Cap

323.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGIN
DCTH
Founded
2019
1988
Country
Singapore
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
332.6M
323.1M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
BGIN
DCTH
Price
$2.92
$9.25
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$23.00
AVG Volume (30 Days)
15.4K
504.2K
Earning Date
03-02-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$205,457,324.00
$79,603,000.00
Revenue This Year
N/A
$132.21
Revenue Next Year
N/A
$33.88
P/E Ratio
N/A
$269.81
Revenue Growth
N/A
251.54
52 Week Low
$2.38
$8.12
52 Week High
$6.50
$18.23

Technical Indicators

Market Signals
Indicator
BGIN
DCTH
Relative Strength Index (RSI) 44.96 42.36
Support Level $2.89 $8.94
Resistance Level $3.04 $10.30
Average True Range (ATR) 0.13 0.52
MACD -0.03 -0.08
Stochastic Oscillator 23.30 23.70

Price Performance

Historical Comparison
BGIN
DCTH

About BGIN Bgin Blockchain Limited Class A Ordinary Shares

BGIN Blockchain Ltd is operating through its subsidiaries and is engaged in digital asset technology company based in Singapore, Hong Kong and the U.S. with proprietary cryptocurrency-mining technologies and a strategic focus on alternative cryptocurrencies. It design and sell mining machines equipped with proprietary 8nm or 12nm ASIC chips under different series dedicated to the mining of KAS coins, ALPH coins, and RXD coins. The Company operated in two reportable segments, which were the cryptocurrency mining and the sale of mining machines Key revenue is generated from Sale of mining machines. Geographically, It derives key revenue from Hong Kong, China and Vietnam, United States, Singapore, etc.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: